190 related articles for article (PubMed ID: 8713470)
1. The ecology and pathology of Epstein-Barr virus.
Schmidt CW; Misko IS
Immunol Cell Biol; 1995 Dec; 73(6):489-504. PubMed ID: 8713470
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Epstein-Barr virus-associated diseases.
Kutok JL; Wang F
Annu Rev Pathol; 2006; 1():375-404. PubMed ID: 18039120
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell growth and death by Epstein-Barr virus.
Wensing B; Farrell PJ
Microbes Infect; 2000 Jan; 2(1):77-84. PubMed ID: 10717544
[TBL] [Abstract][Full Text] [Related]
4. [Epstein-Barr virus].
Tsurumi T
Nihon Rinsho; 2003 Mar; 61 Suppl 3():582-6. PubMed ID: 12718032
[No Abstract] [Full Text] [Related]
5. Adenovirus and Epstein-Barr virus in lung disease.
Hogg JC; Hegele RG
Semin Respir Infect; 1995 Dec; 10(4):244-53. PubMed ID: 8668852
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus: the first human tumor virus and its role in cancer.
Pagano JS
Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection and human malignancies.
Niedobitek G; Meru N; Delecluse HJ
Int J Exp Pathol; 2001 Jun; 82(3):149-70. PubMed ID: 11488990
[TBL] [Abstract][Full Text] [Related]
9. Issues related to development of Epstein-Barr virus vaccines.
Spring SB; Hascall G; Gruber J
J Natl Cancer Inst; 1996 Oct; 88(20):1436-41. PubMed ID: 8841018
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
Young LS; Murray PG
Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
[TBL] [Abstract][Full Text] [Related]
11. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic role of Epstein-Barr virus in human cancer.
Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.
Zalani S; Holley-Guthrie E; Kenney S
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9194-9. PubMed ID: 8799177
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus.
Rickinson A
Virus Res; 2002 Jan; 82(1-2):109-13. PubMed ID: 11885937
[No Abstract] [Full Text] [Related]
16. Epstein-Barr virus genes and cancer cells.
Farrell PJ; Cludts I; Stühler A
Biomed Pharmacother; 1997; 51(6-7):258-67. PubMed ID: 9309246
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) associated lesions of the head and neck.
Boulter A; Johnson NW; Birnbaum W; Teo CG
Oral Dis; 1996 Jun; 2(2):117-24. PubMed ID: 8957923
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus.
IARC Monogr Eval Carcinog Risks Hum; 1997; 70():47-373. PubMed ID: 9612712
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus as an agent of haematological disease.
Tosato G; Taga K; Angiolillo AL; Sgadari C
Baillieres Clin Haematol; 1995 Mar; 8(1):165-99. PubMed ID: 7663046
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus and lymphoma.
Ambinder RF; Lemas MV; Moore S; Yang J; Fabian D; Krone C
Cancer Treat Res; 1999; 99():27-45. PubMed ID: 9891862
[No Abstract] [Full Text] [Related]
[Next] [New Search]
